XML 51 R30.htm IDEA: XBRL DOCUMENT v3.25.0.1
Insider Trading Arrangements
 3 Months Ended 12 Months Ended
Dec. 31, 2024
shares
Dec. 31, 2024
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Dr. Ann S. Blouin [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement   Dr. Ann S. Blouin, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on November 12, 2024. Dr. Blouin's 10b5-1 Plan provides for the sale of up to 450 shares of the Company's common stock between February 11, 2025 and November 11, 2025.
Name Dr. Ann S. Blouin  
Title a member of our Board of Directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date November 12, 2024  
Expiration Date November 11, 2025  
Arrangement Duration 273 days  
Aggregate Available 450 450
Suzanne D. Snapper [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement   Suzanne D. Snapper, Chief Financial Officer, Executive Vice President, and Director, entered into a Rule 10b5-1 trading arrangement on November 15, 2024. Ms. Snapper's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to 10,618 shares of the Company's common stock between February 18, 2025 and July 28, 2025.
Name Suzanne D. Snapper  
Title Chief Financial Officer, Executive Vice President, and Director  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date November 15, 2024  
Expiration Date July 28, 2025  
Arrangement Duration 160 days  
Aggregate Available 10,618 10,618